Published in Br J Cancer on May 17, 2012
Detailed analysis of inflammatory cell infiltration in colorectal cancer. Br J Cancer (2013) 1.30
Tumor-associated neutrophils as a new prognostic factor in cancer: a systematic review and meta-analysis. PLoS One (2014) 1.05
Phenotypic skewing of macrophages in vitro by secreted factors from colorectal cancer cells. PLoS One (2013) 0.99
Circulating IL-6 concentrations link tumour necrosis and systemic and local inflammatory responses in patients undergoing resection for colorectal cancer. Br J Cancer (2013) 0.96
Comment on 'Stage-dependent alterations of the serum cytokine pattern in colorectal carcinoma'. Br J Cancer (2013) 0.94
Pathologic Factors Associated with Prognosis after Adjuvant Chemotherapy in Stage II/III Microsatellite-Unstable Colorectal Cancers. J Pathol Transl Med (2015) 0.92
Characterization of tumor-associated B-cell subsets in patients with colorectal cancer. Oncotarget (2014) 0.89
The in situ local immune response, tumour senescence and proliferation in colorectal cancer. Br J Cancer (2013) 0.87
Prognostic stratification of colorectal cancer patients: current perspectives. Cancer Manag Res (2014) 0.85
Comment on 'Tumour-infiltrating inflammation and prognosis in colorectal cancer: systematic review and meta-analysis'. Br J Cancer (2014) 0.84
Expressions of Matrix Metalloproteinases 2, 7, and 9 in Carcinogenesis of Pancreatic Ductal Adenocarcinoma. Dis Markers (2016) 0.83
Comparison of the prognostic value of measures of the tumor inflammatory cell infiltrate and tumor-associated stroma in patients with primary operable colorectal cancer. Oncoimmunology (2016) 0.79
Response to comment on 'Tumour-infiltrating inflammation and prognosis in colorectal cancer: systematic review and meta-analysis'. Br J Cancer (2014) 0.76
Prognostic impact of tumour-associated B cells and plasma cells in oesophageal and gastric adenocarcinoma. J Gastrointest Oncol (2016) 0.75
Cetuximab strongly enhances immune cell infiltration into liver metastatic sites in colorectal cancer. Cancer Sci (2017) 0.75
Divergent expression of bacterial wall sensing Toll-like receptors 2 and 4 in colorectal cancer. World J Gastroenterol (2017) 0.75
Stromal and intraepithelial tumor-infiltrating lymphocytes in colorectal carcinoma. Oncol Lett (2017) 0.75
Diagnostic value of inflammatory cell infiltrates, tumor stroma percentage and disease-free survival in patients with colorectal cancer. Oncol Lett (2017) 0.75
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science (2006) 24.54
Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer (2004) 14.55
Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med (2005) 12.64
The microenvironment of the tumour-host interface. Nature (2001) 9.17
CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res (1998) 6.42
Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. J Clin Oncol (2008) 6.01
Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol (2010) 4.83
A new prognostic classification of rectal cancer. Lancet (1987) 3.56
Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer. Ann Surg (2007) 3.33
High macrophage infiltration along the tumor front correlates with improved survival in colon cancer. Clin Cancer Res (2007) 2.63
Inflammation and prognosis in colorectal cancer. Eur J Cancer (2005) 2.47
An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer. Proc Nutr Soc (2008) 2.44
Expression of CD68 in non-myeloid cell types. Scand J Immunol (2008) 2.32
Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis. Lab Invest (2004) 2.05
Prognostic role of CD8+ tumor-infiltrating lymphocytes in stage III colorectal cancer with and without microsatellite instability. Hum Pathol (2004) 1.89
Tumor-infiltrating macrophages and dendritic cells in human colorectal cancer: relation to local regulatory T cells, systemic T-cell response against tumor-associated antigens and survival. J Transl Med (2007) 1.51
Prognostic value of tumor-infiltrating dendritic cells in colorectal cancer: role of maturation status and intratumoral localization. Clin Cancer Res (2005) 1.38
Prognostic value of tumour necrosis and host inflammatory responses in colorectal cancer. Br J Surg (2011) 1.33
The role of the in situ local inflammatory response in predicting recurrence and survival in patients with primary operable colorectal cancer. Cancer Treat Rev (2011) 1.29
Invasive front of colorectal cancer: dynamic interface of pro-/anti-tumor factors. World J Gastroenterol (2009) 1.17
Tumour inflammatory infiltrate predicts survival following curative resection for node-negative colorectal cancer. Eur J Cancer (2009) 1.15
Different occurrence of CD8+, CD45R0+, and CD68+ immune cells in regional lymph node metastases from colorectal cancer as potential prognostic predictors. Int J Colorectal Dis (2002) 1.13
The role of CD4+ tumor-infiltrating lymphocytes in human solid tumors. Immunol Res (1995) 1.12
Proliferating endothelial cells and leukocyte infiltration as prognostic markers in colorectal cancer. Clin Gastroenterol Hepatol (2006) 1.05
Character of the invasive margin in colorectal cancer: does it improve prognostic information of Dukes staging? Dis Colon Rectum (1997) 0.95
Counting cells made easier. Histopathology (2006) 0.83
Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. Br J Cancer (2003) 3.44
The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer. Br J Cancer (2002) 2.80
Effect of the inflammatory response on trace element and vitamin status. Ann Clin Biochem (2000) 2.79
Prognostic factors in advanced gastrointestinal cancer patients with weight loss. Nutr Cancer (2000) 2.50
Impact of anastomotic leakage on long-term survival of patients undergoing curative resection for colorectal cancer. Br J Surg (2005) 2.45
Management of the malignant colorectal polyp: ACPGBI position statement. Colorectal Dis (2013) 2.41
A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer. Br J Cancer (2012) 2.41
Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer. Br J Cancer (2004) 2.39
Evaluation of an inflammation-based prognostic score in patients with inoperable gastro-oesophageal cancer. Br J Cancer (2006) 2.33
An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study. Br J Cancer (2011) 2.21
Risk factors for postnatal mother-child transmission of HIV-1. AIDS (2000) 2.08
Risk factors associated with failure of syndromic treatment of sexually transmitted diseases among women seeking primary care in Addis Ababa. Sex Transm Infect (2004) 1.95
Granulomatous lobular mastitis. J Clin Pathol (1987) 1.92
Possible precursor of diaphragm disease in the small intestine. Lancet (1993) 1.92
Evaluating HER2 amplification and overexpression in breast cancer. J Pathol (2001) 1.89
An elevated C-reactive protein concentration, prior to surgery, predicts poor cancer-specific survival in patients undergoing resection for gastro-oesophageal cancer. Br J Cancer (2006) 1.75
Metabolic response to feeding in weight-losing pancreatic cancer patients and its modulation by a fish-oil-enriched nutritional supplement. Clin Sci (Lond) (2000) 1.74
The relationship between the presence and site of cancer, an inflammation-based prognostic score and biochemical parameters. Initial results of the Glasgow Inflammation Outcome Study. Br J Cancer (2010) 1.73
An evaluation of the impact of a multidisciplinary team, in a single centre, on treatment and survival in patients with inoperable non-small-cell lung cancer. Br J Cancer (2005) 1.71
Systemic inflammatory response predicts outcome in patients undergoing resection for ductal adenocarcinoma head of pancreas. Br J Cancer (2005) 1.71
The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer. Br J Cancer (2005) 1.69
Preoperative but not postoperative systemic inflammatory response correlates with survival in colorectal cancer. Br J Surg (2007) 1.62
Relationship of endothelial cell proliferation to tumor vascularity in human breast cancer. Cancer Res (1993) 1.58
The relationship between T-lymphocyte infiltration, stage, tumour grade and survival in patients undergoing curative surgery for renal cell cancer. Br J Cancer (2003) 1.58
The relationship between weight loss and interleukin 6 in non-small-cell lung cancer. Br J Cancer (1996) 1.57
Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer. Br J Cancer (2007) 1.57
Mother-child class I HLA concordance increases perinatal human immunodeficiency virus type 1 transmission. J Infect Dis (1998) 1.51
Surgeons and selection of adjuvant therapy for node-negative colonic cancer. Br J Surg (2010) 1.49
Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer. Br J Cancer (2006) 1.48
A prospective longitudinal study of performance status, an inflammation-based score (GPS) and survival in patients with inoperable non-small-cell lung cancer. Br J Cancer (2005) 1.46
Longitudinal study of weight, appetite, performance status, and inflammation in advanced gastrointestinal cancer. Nutr Cancer (1999) 1.45
Therapeutic implications of the sentinel lymph node in breast cancer. Lancet (1999) 1.45
Comparison of visual and automated assessment of Ki-67 proliferative activity and their impact on outcome in primary operable invasive ductal breast cancer. Br J Cancer (2012) 1.44
The relationship between components of tumour inflammatory cell infiltrate and clinicopathological factors and survival in patients with primary operable invasive ductal breast cancer. Br J Cancer (2012) 1.44
Structural differences between valine-12 and aspartate-12 Ras proteins may modify carcinoma aggression. J Pathol (1999) 1.41
Heterogeneity of mutant versus wild-type Ki-ras in primary and metastatic colorectal carcinomas, and association of codon-12 valine with early mortality. J Pathol (1998) 1.41
Target-controlled infusions of propofol and remifentanil with closed-loop anaesthesia for hepatic resection. Anaesthesia (2002) 1.40
Comparative genomic hybridization analysis of primary colorectal carcinomas and their synchronous metastases. Genes Chromosomes Cancer (1999) 1.40
Elevated circulating interleukin-6 is associated with an acute-phase response but reduced fixed hepatic protein synthesis in patients with cancer. Ann Surg (1991) 1.36
Preoperative systemic inflammation predicts postoperative infectious complications in patients undergoing curative resection for colorectal cancer. Br J Cancer (2009) 1.35
Prognostic value of tumour necrosis and host inflammatory responses in colorectal cancer. Br J Surg (2011) 1.33
Amplification, increased dosage and in situ expression of the telomerase RNA gene in human cancer. Oncogene (1997) 1.33
Impact of weight loss, appetite, and the inflammatory response on quality of life in gastrointestinal cancer patients. Nutr Cancer (1998) 1.31
Chromosome 17 aneusomy is associated with poor prognostic factors in invasive breast carcinoma. Breast Cancer Res Treat (2003) 1.30
The role of the in situ local inflammatory response in predicting recurrence and survival in patients with primary operable colorectal cancer. Cancer Treat Rev (2011) 1.29
The relationship between hypoalbuminaemia, tumour volume and the systemic inflammatory response in patients with colorectal liver metastases. Br J Cancer (2004) 1.27
Male gender adversely affects survival following surgery for colorectal cancer. Br J Surg (2003) 1.26
The relationship between the systemic inflammatory response and survival in patients with transitional cell carcinoma of the urinary bladder. Br J Cancer (2005) 1.24
Comparison of the prognostic value of longitudinal measurements of systemic inflammation in patients undergoing curative resection of colorectal cancer. Br J Cancer (2013) 1.24
Evaluation of the relationship between the systemic inflammatory response and cancer-specific survival in patients with primary operable breast cancer. Br J Cancer (2007) 1.21
The relationship between circulating concentrations of C-reactive protein, inflammatory cytokines and cytokine receptors in patients with non-small-cell lung cancer. Br J Cancer (2004) 1.21
Oral contraceptive use influences resting breast proliferation. Hum Pathol (1989) 1.20
Fibrinogen synthesis is elevated in fasting cancer patients with an acute phase response. J Nutr (1998) 1.19
Albumin synthesis rates are not decreased in hypoalbuminemic cachectic cancer patients with an ongoing acute-phase protein response. Ann Surg (1998) 1.19
Primaquine-induced hemolytic anemia: formation and hemotoxicity of the arylhydroxylamine metabolite 6-methoxy-8-hydroxylaminoquinoline. J Pharmacol Exp Ther (2001) 1.19
Use of inflammatory markers to guide cancer treatment. Clin Pharmacol Ther (2011) 1.18
The systemic inflammatory response, performance status and survival in patients undergoing alpha-interferon treatment for advanced renal cancer. Br J Cancer (2004) 1.17
Systemic inflammation and survival of patients with prostate cancer: evidence from the Glasgow Inflammation Outcome Study. Prostate Cancer Prostatic Dis (2011) 1.17
The relationship between T-lymphocyte subset infiltration and survival in patients with prostate cancer. Br J Cancer (2004) 1.17
Pancreatic cancer as a model: inflammatory mediators, acute-phase response, and cancer cachexia. World J Surg (1999) 1.16
P-glycoprotein expression in primary breast cancer detected by immunocytochemistry with two monoclonal antibodies. Br J Cancer (1990) 1.15
Limb ischaemia after intra-arterial injection of Temazepam gel: histology of nine cases. J Clin Pathol (1994) 1.14
Evaluation of a cumulative prognostic score based on the systemic inflammatory response in patients undergoing potentially curative surgery for colorectal cancer. Br J Cancer (2004) 1.14
The impact of blood loss, obstruction and perforation on survival in patients undergoing curative resection for colon cancer. Br J Surg (2006) 1.13
Tumour T-lymphocyte subset infiltration and tumour recurrence following curative resection for colorectal cancer. Eur J Surg Oncol (2004) 1.12
The relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic and macrophage infiltration, microvessel density and survival in patients with primary operable breast cancer. Br J Cancer (2008) 1.10
The relationship between an inflammation-based prognostic score (Glasgow Prognostic Score) and changes in serum biochemical variables in patients with advanced lung and gastrointestinal cancer. J Clin Pathol (2006) 1.10
Predicting the future: a critical appraisal of cancer prognosis studies. Histopathology (1999) 1.08
The relationship between the preoperative systemic inflammatory response and cancer-specific survival in patients undergoing potentially curative resection for renal clear cell cancer. Br J Cancer (2006) 1.07
Sentinel node localization in patients with breast cancer. Br J Surg (1998) 1.06
Characterization of extensive genetic alterations in ductal carcinoma in situ by fluorescence in situ hybridization and molecular analysis. J Natl Cancer Inst (1995) 1.05
Effect of weight loss and the inflammatory response on leptin concentrations in gastrointestinal cancer patients. Clin Cancer Res (1998) 1.05
The relationship between tumour stroma percentage, the tumour microenvironment and survival in patients with primary operable colorectal cancer. Ann Oncol (2014) 1.03
Rapid sample throughput for biomedical stable isotope tracer studies. Biomed Environ Mass Spectrom (1988) 1.03
The relationship between patient physiology, the systemic inflammatory response and survival in patients undergoing curative resection of colorectal cancer. Br J Cancer (2010) 1.02
Clinical utility of the Glasgow Prognostic Score in patients undergoing curative nephrectomy for renal clear cell cancer: basis of new prognostic scoring systems. Br J Cancer (2011) 1.01
The presence of a systemic inflammatory response predicts poorer survival in patients receiving adjuvant 5-FU chemotherapy following potentially curative resection for colorectal cancer. Br J Cancer (2006) 1.00
The relationship between lymphocyte subsets and clinico-pathological determinants of survival in patients with primary operable invasive ductal breast cancer. Br J Cancer (2013) 1.00
A classical osteogenic sarcoma of the breast: histology, immunohistochemistry and ultrastructure. Histopathology (1986) 1.00
IHC for Her2 with CBE356 antibody is a more accurate predictor of Her2 gene amplification by FISH than HercepTest in breast carcinoma. J Clin Pathol (2005) 0.99